Cornea

Study shows statistically significant improvement for primary endpoint of bulbar conjunctival hyperemia for OTX-DED 0.2 mg and 0.3 mg formulations compared with vehicle hydrogel insert.

Successful treatment options can offer hope for patients with inherited disease.

Approaches include anti-vascular endothelial growth factor agents, fine needle diathermy, and corneal collagen crosslinking.

New acrylic implant provides option for patients with endothelial dysfunction.

Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.

Procedure transfers intact donor nerve fibers to the cornea.

Results from Aurion Biotech's IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.

Cynthia Matossian, MD, FACS, ABES, takes a look at the recent, sudden change in low-payment reimbursement by Medicare Administrative Contractors for LipFlow and MGD procedure codes.

Investigators sought to develop a severity scale for tomographic edema in FECD based on Scheimpflug tomography maps, and to evaluate intra- and inter-observer variation for assessing severity.

A cross sectional study investigated how chronic pain conditions outside of the eye impact corneal sensitivity.

A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.

Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.

A study sought to implement and test a trained deep learning algorithm using pre-operative corneal topography scans in order to classify between keratoconus and normal corneas, stage the disease, and predict whether a patient will be likely to benefit from CXL treatment.

A retrospective review was performed to describe changes in corneal thickness and to identify the incidence of posterior corneal changes characteristic of keratoconus, following DMEK surgery. Here’s what investigators found.

Mutations in this glaucoma-associated gene may be commonly reported in many other neurodegenerative diseases.

Investigators examine usefulness in refractive surgery evaluations.

CXL is safe, effective to perform on younger population, study results show.

Researchers believe the vial has the potential to transform the way corneal grafts are preserved and will provide scientists with a platform to develop customized preservation solutions.

Investigators examine usefulness in refractive surgery evaluations

Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.

A survey by Health Union sheds light on the issues patients are facing and can help ophthalmologists map out dry eye disease treatment strategies.

CAM’s regenerative healing means long-term relief and fewer visits to clinic.

Edward Holland, MD, discusses Aurion Biotech's investigation of an injectable technique where one cornea donor could potentially supply hundreds of patients with treatment for endothelial disease.

Tool for quantifying measures may predict outcomes for patients.

According to Oculus, its Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via an inbuilt display.